Ollerstam Anna, Visser Sandra A G, Duker Göran, Forsberg Tomas, Persson Anna H, Nilsson Lars B, Björkman Jan-Arne, Gabrielsson Johan, Al-Saffar Ahmad
Safety Pharmacology, AstraZeneca R&D Södertälje, SE-151 85 Södertälje, Sweden.
J Pharmacol Toxicol Methods. 2007 Sep-Oct;56(2):131-44. doi: 10.1016/j.vascn.2007.05.002. Epub 2007 May 24.
The aim of the present study was to compare sensitivity in detecting the drug-induced QT interval prolongation in three dog models: conscious telemetered at sinus rhythm and conscious and anesthetized dogs during atrial pacing. The test substances used represent different chemical classes with different pharmacological and pharmacokinetic profiles.
Dofetilide and moxifloxacin were tested in all models, whereas cisapride and terfenadine were tested in the conscious telemetered and paced models. All substances were given as two consecutive 1.5-h intravenous infusions (infusions 1 and 2). The individual concentration-time courses of dofetilide, moxifloxacin, and cisapride were linked to the drug-induced effects on the QT interval and described with a pharmacokinetic-pharmacodynamic model to obtain an estimate of the unbound plasma concentrations at steady state that give a 10- and 20-ms drug-induced QT interval prolongation (CE10ms and CE20ms).
In the conscious telemetered, conscious paced, and anesthetized dog models, the mean CE10ms values were 1.4, 4.0, and 2.5 nM for dofetilide and 1300, 1800, and 12,200 nM for moxifloxacin. For cisapride, the CE10ms values were 8.0 and 4.4 nM in the conscious telemetered and conscious paced dog models. The drug-induced QT interval prolongation during the last 30 min of infusions 1 and 2 was comparable in the conscious models, but smaller in the anesthetized dog model. Terfenadine displayed a marked delay in onset of response, which could only be detected by the extended ECG recording.
All dog models investigated detected QT interval prolongation after administration of the investigated test substances with similar sensitivity, except for a lower sensitivity in the anesthetized dogs following moxifloxacin administration. The conscious telemetered dog model was favorable, mainly due to the extended continuous ECG recording, which facilitated detection and quantification of delayed temporal differences between systemic exposure and drug-induced QT interval prolongation.
本研究的目的是比较三种犬模型检测药物诱导的QT间期延长的敏感性:窦性心律下的清醒遥测犬以及心房起搏时的清醒和麻醉犬。所使用的受试物质代表具有不同药理和药代动力学特征的不同化学类别。
多非利特和莫西沙星在所有模型中进行测试,而西沙必利和特非那定在清醒遥测和起搏模型中进行测试。所有物质均连续进行两次1.5小时的静脉输注(输注1和输注2)。多非利特、莫西沙星和西沙必利的个体浓度-时间过程与药物对QT间期的影响相关联,并用药代动力学-药效学模型进行描述,以获得稳态下使药物诱导的QT间期延长10毫秒和20毫秒时的游离血浆浓度估计值(CE10ms和CE20ms)。
在清醒遥测、清醒起搏和麻醉犬模型中,多非利特的平均CE10ms值分别为1.4、4.0和2.5纳摩尔,莫西沙星的平均CE10ms值分别为1300、1800和12200纳摩尔。对于西沙必利,在清醒遥测和清醒起搏犬模型中的CE10ms值分别为8.0和4.4纳摩尔。在输注1和2的最后30分钟内,清醒模型中药物诱导的QT间期延长相当,但在麻醉犬模型中较小。特非那定显示出明显的反应延迟,只能通过延长的心电图记录检测到。
除了麻醉犬在给予莫西沙星后敏感性较低外,所有研究的犬模型在给予受试物质后检测QT间期延长的敏感性相似。清醒遥测犬模型是有利的,主要是因为延长的连续心电图记录有助于检测和量化全身暴露与药物诱导的QT间期延长之间的延迟时间差异。